Livongo CEO, Zane Burke, has been a busy guy since the company’s IPO late last year. The applied health signals company has seen triple-digit (148%) growth and a robust expansion of the weight management and behavioral health platforms they’ve been building to support the ‘whole health life’ of people with diabetes. Case-in-point, Zane talks through the outcomes of the company’s latest clinical research on Livongo’s hypertension management tool, which showed that clients who used both Livongo’s diabetes management tool and hypertension tool in tandem experienced significant decreases in their hypertensive blood pressure in as little as four weeks. As traditional healthcare companies and digital health startups alike continue to watch Livongo’s every move for an indication of ‘what’s possible’ for health tech startups, we asked Zane to clue us in on how he’s keeping his team focused on product development, market expansion, and issues related to reimbursement.
Filmed at Frontiers Health in Berlin, Germany, November 2019.
What can you learn about building a successful health tech company from the guy who took Allscripts public? What if you add the former CEO of Cerner to the conversation? Glen Tullman, Executive Chairman of Livongo, introduces his new CEO, Zane Burke, and shares the details about how they’re expanding their chronic condition management platform beyond diabetes. The two talk strategy, acquisition, building bench strength, culture, and fundraising…right in front of an inflatable unicorn. A hint of things to come? Will Livongo go public?? Listen in to find out.
Filmed at HIMSS 2019 in Orlando, Florida, February 2019.
Jessica DaMassa is the host of the WTF Health show & stars in Health in 2 Point 00 with Matthew Holt.
Get a glimpse of the future of healthcare by meeting the people who are going to change it. Find more WTF Health interviews here or check out www.wtf.health.
Today on Health in 2 Point 00, Jess and I get festive for the holidays. In this episode, Jess asks me about Walgreens and its new partnership with FedEx for next day prescription delivery and with Verily to help patients with prescription adherence. She also asks me about blockchain startup PokitDok getting its assets acquired by Change Healthcare. Lots of job changes are happening as well. Amy Abernethy, the chief medical officer at Flatiron Health, was named Deputy Commissioner of the FDA. Rasu Shrestha, who was previously at the University of Pittsburgh Medical Center, is the new chief strategy officer of Atrium Health. Finally, Zane Burke, who recently stepped down as president of Cerner, was just hired as Livongo’s new CEO, while Glen Tullman remains executive chairman of the company. Dr. Jennifer Schneider was also promoted from the company’s chief medical officer to president. We have one more episode of Health in 2 Point 00 for 2018, so be on the lookout for our year-end wrap-up. —Matthew Holt